Literature DB >> 24875487

Urinary albumin to creatinine ratio as potential biomarker for cerebral microvascular disease.

Amanda L Strickland, Heidi C Rossetti, Ronald M Peshock, Myron F Weiner, Paul A Nakonezny, Roderick W McColl, Keith M Hulsey, Sandeep R Das, Kevin S King1.   

Abstract

Elevated urinary albumin to creatinine ratio (ACR) and white matter hyperintensity (WMH) volume seen on brain MRI are measures of microvascular disease which may have shared susceptibility to metabolic and vascular insults. We hypothesized that elevated ACR may be useful as inexpensive biomarker to predict presence of cerebral microvascular disease. We assessed the association between ACR at study entry and subsequent WMH volume. We evaluated pulse pressure, mean arterial pressure, hypertension duration, waist circumference, fasting glucose, glomerular filtration rate (GFR) and C-reactive protein (CRP) as potential mediators and diabetes as a moderator of the association between ACR and WMH. Data were collected at study entry and at follow-up approximately 7 years later in a multiethnic population sample of 1281 participants (mean age = 51, SD = 9.5) from Dallas County. Overall, ACR differences were only marginally (p = 0.05) associated with subsequent WMH. In mediator analysis, however, ACR differences related specifically to arterial pulsatility(β = 0.010, bootstrap 95% Confidence Interval (CI): 0.002 to 0.021) and waist circumference (β = -0.004, bootstrap 95% CI: -0.011 to -0.001) were significantly associated with WMH. ACR differences related to serum glucose and CRP were not associated with WMH. ACR evaluated at the same time as WMH had a higher level of significance (p < 0.001) indicating greater utility in predicting current cerebrovascular insults.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24875487      PMCID: PMC4795813          DOI: 10.2174/1567202611666140530130327

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  34 in total

Review 1.  Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association.

Authors:  Cora E Lewis; Kathleen M McTigue; Lora E Burke; Paul Poirier; Robert H Eckel; Barbara V Howard; David B Allison; Shiriki Kumanyika; F Xavier Pi-Sunyer
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

2.  Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods       Date:  2008-08

3.  White matter hyperintensities: use of aortic arch pulse wave velocity to predict volume independent of other cardiovascular risk factors.

Authors:  Kevin S King; Ke Xun Chen; Keith M Hulsey; Roderick W McColl; Myron F Weiner; Paul A Nakonezny; Ronald M Peshock
Journal:  Radiology       Date:  2013-02-07       Impact factor: 11.105

4.  Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.

Authors:  W L Roberts; L Moulton; T C Law; G Farrow; M Cooper-Anderson; J Savory; N Rifai
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?

Authors:  Frank A Provenzano; Jordan Muraskin; Giuseppe Tosto; Atul Narkhede; Ben T Wasserman; Erica Y Griffith; Vanessa A Guzman; Irene B Meier; Molly E Zimmerman; Adam M Brickman
Journal:  JAMA Neurol       Date:  2013-04       Impact factor: 18.302

7.  Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.

Authors:  Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

8.  Microalbuminuria and endothelial dysfunction in essential hypertension.

Authors:  R Pedrinelli; O Giampietro; F Carmassi; E Melillo; G Dell'Omo; G Catapano; E Matteucci; L Talarico; M Morale; F De Negri
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321

9.  Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.

Authors:  C Jongen; J van der Grond; L J Kappelle; G J Biessels; M A Viergever; J P W Pluim
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

Review 10.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

View more
  1 in total

1.  Low grade albuminuria as a risk factor for subtypes of stroke - the HUNT Study in Norway.

Authors:  Jens W Horn; Solfrid Romundstad; Hanne Ellekjær; Imre Janszky; Julie Horn
Journal:  BMC Neurol       Date:  2020-05-02       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.